Condensed Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Loss	$ (18,945,059)	$ (34,040,132)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of deferred revenue	(1,917,244)	(2,185,539)
Amortization of deferred credit	(87,570)	(38,920)
Amortization of debt discounts and deferred financing fees	3,440,492	2,057,892
Non-cash equity compensation	1,028,814	1,242,450
Depreciation and amortization of long-lived assets	586,233	529,978
Inventory reserve provision	19,219
Loss on sale of patents		824,241
Loss on investment in Tarsa	650,571	2,819,143
Loss on investment in former China Joint Venture	600,000	1,375,925
Loss on change in fair value of embedded conversion feature	1,870,000	12,120,000
Changes in operating assets and liabilities:
Decrease (increase) in accounts receivable	1,017,129	(294,555)
Decrease in inventory	1,120,628	607,211
Decrease in other assets	1,070,655	223,668
Decrease in accounts payable and accrued expenses	(1,226,312)	(451,661)
Increase in deferred revenue	1,466,318	4,717,312
Increase in accrued interest	6,153,166	5,873,897
Increase (decrease) in deferred compensation	32,303	(7,850)
Net cash used in operating activities	(3,120,657)	(4,626,940)
CASH FLOWS FROM INVESTING ACTIVITIES:
Investment in Tarsa	(650,571)	(2,819,143)
Investment in Nordic joint venture	(50,000)
Capital expenditures	(149,792)	(642,697)
Proceeds from sale of patents		20,000
Increase in patents and other intangibles	(118,719)	(244,388)
Proceeds from sale/lease back		1,119,963
Net cash used in investing activities	(969,082)	(2,566,265)
CASH FLOWS FROM FINANCING ASSETS:
Repayment of Founders’ note	(300,000)
Repayment of capital lease	(44,187)
Proceeds from issuance of debt	4,000,000
Debt issuance costs	(262,000)
Proceeds from exercise of stock options	13,110	185,424
Net cash provided by financing activities	3,406,923	185,424
Net decrease in cash and cash equivalents	(682,816)	(7,007,781)
Cash and cash equivalents at beginning of period	4,681,683	12,200,800
Cash and cash equivalents at end of period	$ 3,998,867	$ 5,193,019
Non-cash investing and financing activities:
Purchase of equipment through capital lease	$119,772	$--